Koch Hall

Illuminating the path of care for a multifaceted disease

Morning Session

Alice Cheng (Canada), Robert Ritzel (Germany)
Opening video, welcome and introduction
James Gavin III (USA)
Keynote lecture: Diabetes a heterogeneous and complex disease

Athena Philis-Tsimikas (USA)
Session introduction
Richard Bergenstal (USA)
From Banting to smart insulins: Advancing insulin technology
Alice Cheng (Canada)
The BRIGHT study: The first large head-to-head comparison of second-generation basal insulin analogs
Vicki Seyfert-Margolis (USA)
Advances in real-world evidence methodology: What big data is teaching us
Luigi Meneghini (USA)
Beyond RCTs: A comprehensive approach to understanding diabetes
Stewart Harris (Canada), John Wilding (UK)
The symbiosis of real-world evidence and RCTs
Q&A / Panel discussion
Athena Philis-Tsimikas (USA)
Session summary

Robert Ritzel (Germany)
Session introduction
Patients uncontrolled on basal insulins
Rory McCrimmon (UK)
A combination approach: targeting multiple defects of diabetes
Daniël can Raalte (The Netherlands)
Fixed-ratio combinations: Which patients can benefit?
Patients with T1DM with frequent hypoglycemia and/or glycemic variability
Thomas Danne (Germany)
Beyond glucose control: Living with diabetes
Julio Rosenstock (USA)
One drug, two mechanisms: An SGLT-1 and SGLT-2 inhibitor
Patients at high risk of CVD
Naveed Sattar (UK)
How to address residual CV risk in individuals with DM
Rafael Diaz
ODYSSEY OUTCOMES: Long-term cardiovascular outcomes in overall post-ACS and in sub-populations
Panel discussion and meeting summary
Alice cheng (Canada), Robert Ritzel (Germany)
Illuminating the path ahead
Symposia by: